A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment

Phase 1B ◽

Met Inhibitor

A Mathematical Model for Assessing KRAS Mutation Effect on Monoclonal Antibody Treatment of Colorectal Cancer

Software Engineering and Formal Methods - Lecture Notes in Computer Science ◽

10.1007/978-3-319-15201-1_16 ◽

2015 ◽

pp. 243-258

Author(s):

Sheema Sameen ◽

Roberto Barbuti ◽

Paolo Milazzo ◽

Antonio Cerone

Keyword(s):

Colorectal Cancer ◽

Mathematical Model ◽

Monoclonal Antibody ◽

Kras Mutation ◽

Antibody Treatment ◽

Management of Skin Toxicity Associated with EGFR-targeted Monoclonal Antibody Treatment for Advanced Colorectal Cancer: A Single Center Experience

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) ◽

10.4030/jjcs.38.279 ◽

2013 ◽

Vol 38 (2) ◽

pp. 279-285

Author(s):

Atsuko Fukazawa ◽

Akihiro Uno ◽

Osamu Jindo ◽

Keigo Matsumoto ◽

Hideto Ochiai ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Advanced Colorectal Cancer ◽

Skin Toxicity ◽

Single Center ◽

Antibody Treatment ◽

Single Center Experience ◽

Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2211-0 ◽

2013 ◽

Vol 72 (2) ◽

pp. 397-403 ◽

Cited By ~ 11

Author(s):

David Tougeron ◽

Ulrich Cortes ◽

Aurélie Ferru ◽

Claire Villalva ◽

Christine Silvain ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Antibody Treatment ◽

Kras Mutations ◽

Epidermal Growth

Reply to `Comment on `Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study''

British Journal of Cancer ◽

10.1038/s41416-018-0040-y ◽

2018 ◽

Vol 118 (9) ◽

pp. 1278-1279

Author(s):

Eiji Shinozaki ◽

Takayuki Yoshino ◽

Katsuya Tsuchihara

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Monoclonal Antibodies ◽

Metastatic Colorectal Cancer ◽

Clinical Significance ◽

Cancer Genomics ◽

Therapeutic Effects ◽

Antibody Treatment ◽

Biomarker Research

Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study

British Journal of Cancer ◽

10.1038/bjc.2017.308 ◽

2017 ◽

Vol 117 (10) ◽

pp. 1450-1458 ◽

Cited By ~ 31

Author(s):

Eiji Shinozaki ◽

Takayuki Yoshino ◽

Kentaro Yamazaki ◽

Kei Muro ◽

Kensei Yamaguchi ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Monoclonal Antibodies ◽

Metastatic Colorectal Cancer ◽

Clinical Significance ◽

Cancer Genomics ◽

Therapeutic Effects ◽

Antibody Treatment ◽

Biomarker Research

Monoclonal antibody treatment of colorectal cancer

British Journal of Surgery ◽

10.1111/j.1365-2168.1997.00560.x ◽

1997 ◽

Vol 84 (11) ◽

pp. 1511-1517 ◽

Cited By ~ 1

Author(s):

A. M. PULLYBLANK ◽

J. R. T. MONSON

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Antibody Treatment ◽

Molecular Markers for the Prediction of Anti-EGFR Monoclonal Antibody Treatment Efficacy in Metastatic Colorectal Cancer

Journal of Cancer Therapy ◽

10.4236/jct.2011.25090 ◽

2011 ◽

Vol 02 (05) ◽

pp. 675-682 ◽

Cited By ~ 3

Author(s):

Cheng-Bo Han ◽

Jie-Tao Ma ◽

Fan Li ◽

Hua-Wei Zou

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Molecular Markers ◽

Metastatic Colorectal Cancer ◽

Treatment Efficacy ◽

Antibody Treatment ◽

Monoclonal antibody treatment of colorectal cancer

British Journal of Surgery ◽

10.1002/bjs.1800841106 ◽

1997 ◽

Vol 84 (11) ◽

pp. 1511-1517 ◽

Cited By ~ 10

Author(s):

A. M. Pullyblank ◽

J. R. T. Monson

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Antibody Treatment ◽

Anti-EGFR monoclonal antibody treatment in colorectal cancer

Nature Clinical Practice Gastroenterology &#38 Hepatology ◽

10.1038/ncpgasthep0180 ◽

2005 ◽

Vol 2 (6) ◽

pp. 249-250

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Antibody Treatment ◽

Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer

Scientific Reports ◽

10.1038/srep08013 ◽

2015 ◽

Vol 5 (1) ◽

Cited By ~ 5

Author(s):

Avisek Deyati ◽

Shweta Bagewadi ◽

Philipp Senger ◽

Martin Hofmann-Apitius ◽

Natalia Novac

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Systems Approach ◽

Antibody Treatment ◽

Micro Rnas ◽

Selection Of